{"id":"https://openalex.org/W2609525945","doi":"https://doi.org/10.1111/nyas.13347","title":"Equivalence of complex drug products: advances in and challenges for current regulatory frameworks","display_name":"Equivalence of complex drug products: advances in and challenges for current regulatory frameworks","alternate_titles":[],"publication_year":2017,"publication_date":"2017-04-26","ids":{"openalex":"https://openalex.org/W2609525945","doi":"https://doi.org/10.1111/nyas.13347","mag":"2609525945","pmid":"https://pubmed.ncbi.nlm.nih.gov/28445611"},"language":"en","primary_location":{"id":"doi:10.1111/nyas.13347","doi":"https://doi.org/10.1111/nyas.13347","is_oa":true,"landing_page_url":"https://doi.org/10.1111/nyas.13347","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/nyas.13347","source":{"id":"https://openalex.org/S8802318","display_name":"Annals of the New York Academy of Sciences","issn_l":"0077-8923","issn":["0077-8923","1749-6632"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the New York Academy of Sciences","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2609525945"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/nyas.13347","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037403014","display_name":"Leonie Hussaarts","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133293","display_name":"Lygature","ror":"https://ror.org/02vtk3a57","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I4210133293"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Leonie Hussaarts","raw_affiliation_strings":["Lygature, Utrecht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lygature, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I4210133293"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071198933","display_name":"Stefan M\u00fchlebach","orcid":"https://orcid.org/0000-0002-8471-7513","observed_orcids":["https://orcid.org/0000-0002-8471-7513"]},"institutions":[{"id":"https://openalex.org/I4210102083","display_name":"Vifor Pharma (Switzerland)","ror":"https://ror.org/0185z7g17","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210102083"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Stefan M\u00fchlebach","raw_affiliation_strings":["Vifor Pharma Ltd., Glattbrugg, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vifor Pharma Ltd., Glattbrugg, Switzerland","institution_ids":["https://openalex.org/I4210102083"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108461895","display_name":"Vinod P. Shah","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vinod P. Shah","raw_affiliation_strings":["Pharmaceutical Consultant, North Potomac, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Consultant, North Potomac, Maryland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020993025","display_name":"Scott E. McNeil","orcid":"https://orcid.org/0000-0002-7575-5198","observed_orcids":["https://orcid.org/0000-0002-7575-5198","https://orcid.org/0000-0001-7035-075X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Scott McNeil","raw_affiliation_strings":["Nanotechnology Characterization Laboratory, Frederick, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nanotechnology Characterization Laboratory, Frederick, Maryland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053220835","display_name":"Gerrit Borchard","orcid":"https://orcid.org/0000-0001-6268-2586","observed_orcids":["https://orcid.org/0000-0001-6268-2586"]},"institutions":[{"id":"https://openalex.org/I114457229","display_name":"University of Geneva","ror":"https://ror.org/01swzsf04","country_code":"CH","type":"education","lineage":["https://openalex.org/I114457229"]},{"id":"https://openalex.org/I97565354","display_name":"University of Lausanne","ror":"https://ror.org/019whta54","country_code":"CH","type":"education","lineage":["https://openalex.org/I97565354"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Gerrit Borchard","raw_affiliation_strings":["University of Geneva-University of Lausanne, Geneva, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Geneva-University of Lausanne, Geneva, Switzerland","institution_ids":["https://openalex.org/I114457229","https://openalex.org/I97565354"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037316005","display_name":"Beat Fl\u00fchmann","orcid":"https://orcid.org/0000-0002-3077-298X","observed_orcids":["https://orcid.org/0000-0002-3077-298X"]},"institutions":[{"id":"https://openalex.org/I4210102083","display_name":"Vifor Pharma (Switzerland)","ror":"https://ror.org/0185z7g17","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210102083"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Beat Fl\u00fchmann","raw_affiliation_strings":["Vifor Pharma Ltd., Glattbrugg, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vifor Pharma Ltd., Glattbrugg, Switzerland","institution_ids":["https://openalex.org/I4210102083"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004540049","display_name":"Vera Weinstein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109720","display_name":"Teva Pharmaceuticals (Israel)","ror":"https://ror.org/01wfv3m53","country_code":"IL","type":"company","lineage":["https://openalex.org/I4210109720"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Vera Weinstein","raw_affiliation_strings":["Teva Pharmaceuticals, Petach Tikva, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceuticals, Petach Tikva, Israel","institution_ids":["https://openalex.org/I4210109720"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006923214","display_name":"Sesha Neervannan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sesha Neervannan","raw_affiliation_strings":["Allergen Plc, Irvine, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Allergen Plc, Irvine, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076432754","display_name":"Elwyn Griffiths","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elwyn Griffiths","raw_affiliation_strings":["Member of the WHO Advisory Panel on Biological Standardization, Kingston upon Thames, Surrey, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Member of the WHO Advisory Panel on Biological Standardization, Kingston upon Thames, Surrey, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103049255","display_name":"Wenlei Jiang","orcid":"https://orcid.org/0009-0009-3876-638X","observed_orcids":["https://orcid.org/0009-0009-3876-638X"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wenlei Jiang","raw_affiliation_strings":["United States Food and Drug Administration, Silver Spring, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"United States Food and Drug Administration, Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058787149","display_name":"Elena Wolff\u2010Holz","orcid":"https://orcid.org/0000-0002-8129-7381","observed_orcids":["https://orcid.org/0000-0002-8129-7381"]},"institutions":[{"id":"https://openalex.org/I884002606","display_name":"Paul Ehrlich Institut","ror":"https://ror.org/00yssnc44","country_code":"DE","type":"facility","lineage":["https://openalex.org/I884002606"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Elena Wolff\u2010Holz","raw_affiliation_strings":["Paul Ehrlich Institute, Langen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Paul Ehrlich Institute, Langen, Germany","institution_ids":["https://openalex.org/I884002606"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022480241","display_name":"Daan J.A. Crommelin","orcid":"https://orcid.org/0000-0003-0216-5039","observed_orcids":["https://orcid.org/0000-0003-0216-5039"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Daan J.A. Crommelin","raw_affiliation_strings":["Utrecht University, Utrecht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Utrecht University, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I193662353"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070250753","display_name":"Jon S. B. de Vlieger","orcid":"https://orcid.org/0000-0002-9291-3549","observed_orcids":["https://orcid.org/0000-0002-9291-3549"]},"institutions":[{"id":"https://openalex.org/I4210133293","display_name":"Lygature","ror":"https://ror.org/02vtk3a57","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I4210133293"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Jon S.B. de Vlieger","raw_affiliation_strings":["Lygature, Utrecht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lygature, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I4210133293"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5022480241"],"corresponding_institution_ids":["https://openalex.org/I193662353"],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":{"value":5080,"currency":"USD","value_usd":5080},"fwci":4.0243,"has_fulltext":true,"cited_by_count":102,"citation_normalized_percentile":{"value":0.94922005,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"1407","issue":"1","first_page":"39","last_page":"49"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9164999723434448,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9164999723434448,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.07800000160932541,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/follow-on-drugs","display_name":"follow-on drugs","score":0.656000018119812},{"id":"https://openalex.org/keywords/generic-drugs","display_name":"generic drugs","score":0.8510000109672546},{"id":"https://openalex.org/keywords/biologics","display_name":"biologics","score":0.9490000009536743},{"id":"https://openalex.org/keywords/nanomedicine","display_name":"nanomedicine","score":0.8889999985694885},{"id":"https://openalex.org/keywords/liposomes","display_name":"liposomes","score":0.7509999871253967},{"id":"https://openalex.org/keywords/emulsions","display_name":"emulsions","score":0.7699999809265137},{"id":"https://openalex.org/keywords/glatiramer-acetate","display_name":"glatiramer acetate","score":0.6840000152587891},{"id":"https://openalex.org/keywords/regulatory-framework","display_name":"regulatory framework","score":0.8999999761581421},{"id":"https://openalex.org/keywords/fda","display_name":"FDA","score":0.7760000228881836},{"id":"https://openalex.org/keywords/ema","display_name":"EMA","score":0.9729999899864197},{"id":"https://openalex.org/keywords/world-health-organization","display_name":"World Health Organization","score":0.9860000014305115},{"id":"https://openalex.org/keywords/substandard-medicines","display_name":"substandard medicines","score":0.800000011920929},{"id":"https://openalex.org/keywords/critical-attributes","display_name":"critical attributes","score":0.36000001430511475}],"concepts":[{"id":"https://openalex.org/C2776473838","wikidata":"https://www.wikidata.org/wiki/Q174165","display_name":"Innovator","level":3,"score":0.7764259576797485},{"id":"https://openalex.org/C2778917124","wikidata":"https://www.wikidata.org/wiki/Q7309705","display_name":"Regulatory science","level":2,"score":0.7582505941390991},{"id":"https://openalex.org/C3018890749","wikidata":"https://www.wikidata.org/wiki/Q204711","display_name":"Food and drug administration","level":2,"score":0.517379879951477},{"id":"https://openalex.org/C2778605646","wikidata":"https://www.wikidata.org/wiki/Q223729","display_name":"White paper","level":2,"score":0.486695796251297},{"id":"https://openalex.org/C108170787","wikidata":"https://www.wikidata.org/wiki/Q3951828","display_name":"Agency (philosophy)","level":2,"score":0.4686650037765503},{"id":"https://openalex.org/C41458344","wikidata":"https://www.wikidata.org/wiki/Q732577","display_name":"Publication","level":2,"score":0.44387489557266235},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.42155230045318604},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.4203374683856964},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.37050896883010864},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.35657641291618347},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.3361780047416687},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.3137044906616211},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2990626096725464},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2814900875091553},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.136198490858078},{"id":"https://openalex.org/C34974158","wikidata":"https://www.wikidata.org/wiki/Q131257","display_name":"Intellectual property","level":2,"score":0.12471702694892883},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.11658239364624023},{"id":"https://openalex.org/C36289849","wikidata":"https://www.wikidata.org/wiki/Q34749","display_name":"Social science","level":1,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005060","descriptor_name":"Europe","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013810","descriptor_name":"Therapeutic Equivalency","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014486","descriptor_name":"United States Food and Drug Administration","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true},{"descriptor_ui":"D014944","descriptor_name":"World Health Organization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016568","descriptor_name":"Drugs, Generic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D050997","descriptor_name":"Nanomedicine","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D050997","descriptor_name":"Nanomedicine","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/nyas.13347","doi":"https://doi.org/10.1111/nyas.13347","is_oa":true,"landing_page_url":"https://doi.org/10.1111/nyas.13347","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/nyas.13347","source":{"id":"https://openalex.org/S8802318","display_name":"Annals of the New York Academy of Sciences","issn_l":"0077-8923","issn":["0077-8923","1749-6632"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the New York Academy of Sciences","raw_type":"journal-article"},{"id":"pmid:28445611","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28445611","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the New York Academy of Sciences","raw_type":"Conference Proceedings"},{"id":"pmh:oai:edoc.unibas.ch:72671","doi":null,"is_oa":false,"landing_page_url":"https://edoc.unibas.ch/72671/","pdf_url":null,"source":{"id":"https://openalex.org/S4306401836","display_name":"edoc (University of Basel)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1850255","host_organization_name":"University of Basel","host_organization_lineage":["https://openalex.org/I1850255"],"host_organization_lineage_names":[],"type":"repository"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1111/nyas.13347","doi":"https://doi.org/10.1111/nyas.13347","is_oa":true,"landing_page_url":"https://doi.org/10.1111/nyas.13347","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/nyas.13347","source":{"id":"https://openalex.org/S8802318","display_name":"Annals of the New York Academy of Sciences","issn_l":"0077-8923","issn":["0077-8923","1749-6632"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the New York Academy of Sciences","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.504800021648407,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307856","display_name":"World Health Organization","ror":"https://ror.org/01f80g185"},{"id":"https://openalex.org/F4320332163","display_name":"U.S. Food and Drug Administration","ror":"https://ror.org/034xvzb47"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2609525945.pdf","grobid_xml":"https://content.openalex.org/works/W2609525945.grobid-xml"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W380092721","https://openalex.org/W812242640","https://openalex.org/W1121559727","https://openalex.org/W1567847444","https://openalex.org/W1908392151","https://openalex.org/W1993527690","https://openalex.org/W2006188909","https://openalex.org/W2007852467","https://openalex.org/W2023807542","https://openalex.org/W2052539116","https://openalex.org/W2064620980","https://openalex.org/W2072068953","https://openalex.org/W2080690089","https://openalex.org/W2081303262","https://openalex.org/W2094764990","https://openalex.org/W2105608359","https://openalex.org/W2115586444","https://openalex.org/W2117059048","https://openalex.org/W2125134781","https://openalex.org/W2142161221","https://openalex.org/W2175673889","https://openalex.org/W2178617876","https://openalex.org/W2180702805","https://openalex.org/W2182478365","https://openalex.org/W2185449512","https://openalex.org/W2198009032","https://openalex.org/W2228271062","https://openalex.org/W2288929578","https://openalex.org/W2328831958","https://openalex.org/W2421275313","https://openalex.org/W2483262848","https://openalex.org/W2504512426","https://openalex.org/W2507169934","https://openalex.org/W2524334680","https://openalex.org/W2528498003","https://openalex.org/W2582287767"],"related_works":["https://openalex.org/W2766327293","https://openalex.org/W2086438722","https://openalex.org/W2795003444","https://openalex.org/W1918017297","https://openalex.org/W2475905798","https://openalex.org/W4287511598","https://openalex.org/W1993527690","https://openalex.org/W2519478416","https://openalex.org/W4367844929","https://openalex.org/W2157966901"],"abstract_inverted_index":{"Biotechnology":[0],"and":[1,12,42,72,89,127,131,185,191],"nanotechnology":[2],"provide":[3],"a":[4,51,109],"growing":[5],"number":[6,110,141],"of":[7,20,59,94,103,111,137,142,150,187],"innovator-driven":[8],"complex":[9,21,28,86,105,189,197],"drug":[10,29,87,198],"products":[11,88,199],"their":[13,90],"copy":[14],"versions.":[15,92],"Biologics":[16],"exemplify":[17],"one":[18],"category":[19],"drugs,":[22],"but":[23],"there":[24],"are":[25,200],"also":[26],"nonbiological":[27],"products,":[30,190],"including":[31],"many":[32],"nanomedicines,":[33],"such":[34],"as":[35],"iron-carbohydrate":[36],"complexes,":[37],"drug-carrying":[38],"liposomes":[39],"or":[40],"emulsions,":[41],"glatiramoids.":[43],"In":[44],"this":[45],"white":[46],"paper,":[47],"which":[48,114],"stems":[49],"from":[50,125,134],"1-day":[52],"conference":[53],"at":[54],"the":[55,69,75,79,95,119,138,160,167,174,177],"New":[56],"York":[57],"Academy":[58],"Sciences,":[60],"we":[61],"discuss":[62],"regulatory":[63,132,193],"frameworks":[64],"in":[65,166,173],"use":[66],"worldwide":[67,181],"(e.g.,":[68],"U.S.":[70],"Food":[71],"Drug":[73],"Administration,":[74],"European":[76],"Medicines":[77],"Agency,":[78],"World":[80],"Health":[81],"Organization)":[82],"to":[83,100,153,162,170,179],"approve":[84],"these":[85,104,188],"follow-on":[91,157],"One":[93],"key":[96],"questions":[97],"remains":[98],"how":[99],"assess":[101],"equivalence":[102,155],"products.":[106],"We":[107],"identify":[108],"points":[112],"for":[113,156],"consensus":[115,182],"was":[116],"found":[117],"among":[118],"stakeholders":[120],"who":[121],"were":[122,146],"present:":[123],"scientists":[124],"innovator":[126],"generic/follow-on":[128],"companies,":[129],"academia,":[130],"bodies":[133],"different":[135],"parts":[136],"world.":[139],"A":[140],"topics":[143],"requiring":[144],"follow-up":[145],"identified:":[147],"(1)":[148],"assessment":[149],"critical":[151],"attributes":[152],"establish":[154],"versions,":[158],"(2)":[159],"need":[161],"publish":[163],"scientific":[164],"findings":[165],"public":[168],"domain":[169],"further":[171],"progress":[172],"field,":[175],"(3)":[176],"necessity":[178],"develop":[180],"regarding":[183],"nomenclature":[184],"labeling":[186],"(4)":[192],"actions":[194],"when":[195],"substandard":[196],"identified.":[201]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2609525945","counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":9}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2017-05-05T00:00:00"}
